Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000039

CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $84.26 ($1,263,912)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-07-23 Option exercise 10b5-1 +15,000 $2.03 $30,450 493,888 D: show line 1 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-07-23 Sale 10b5-1 −5,718 $83.83 $479,323 488,170 D: show line 2 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-07-23 Sale 10b5-1 −9,282 $84.53 $784,589 478,888 D: show line 3 in the form
Open-market sales · 15,000 sh · avg $84.26 · $1,263,912

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-07-23 Option exercise · Stock Option (right to buy) 10b5-1 −15,000 182,327 D: show line 4 in the form
Loading xslF345X05/wk-form4_1721857439.xml…